FDA approval of your Investigational New Drug (IND) application is the result of a successful drug development program, which begins with STILLMEADOW, Inc.
From guidance in the creation of unique pilot studies and protocols, to evaluation of the safety and efficacy of your product, STILLMEADOW, Inc.’s experienced study directors and laboratory technicians support your drug development in meeting FDA guidelines for advancement to clinical trials.
- Pharmacokinetic (PK) analysis of drug absorption, distribution, metabolism and excretion (ADME)
- Acute and subchronic toxicological parameters
- Dose range-finding studies
- Multiple species
- Creation of unique pilot studies and protocols to meet FDA guidelines
STILLMEADOW, Inc. performs pre-clinical safety and efficacy studies, pharmacokinetic studies, and ADME (adsorption, distribution, metabolism and excretion) studies.